pI: 6.5003 |
Length (AA): 423 |
MW (Da): 48755 |
Paralog Number:
4
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_126781)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G01560 | mitogen-activated protein kinase 11 |
Arabidopsis thaliana | AT2G18170 | mitogen-activated protein kinase 7 |
Arabidopsis thaliana | AT3G45640 | mitogen-activated protein kinase 3 |
Arabidopsis thaliana | AT4G01370 | mitogen-activated protein kinase 4 |
Arabidopsis thaliana | AT3G59790 | mitogen-activated protein kinase 10 |
Arabidopsis thaliana | AT4G11330 | mitogen-activated protein kinase 5 |
Arabidopsis thaliana | AT4G36450 | mitogen-activated protein kinase 14 |
Arabidopsis thaliana | AT1G10210 | mitogen-activated protein kinase 1 |
Arabidopsis thaliana | AT1G59580 | mitogen-activated protein kinase 2 |
Arabidopsis thaliana | AT1G07880 | mitogen-activated protein kinase 13 |
Arabidopsis thaliana | AT2G43790 | MAP kinase 6 |
Brugia malayi | Bm1_46485 | MAP kinase sur-1 |
Candida albicans | CaO19.10404 | MAP kinase-like orf |
Candida albicans | CaO19.2886 | MAP kinase-like orf |
Candida albicans | CaO19.8091 | Serine/threonine protein kinase of MAP kinase family |
Candida albicans | CaO19.7523 | MAP kinase implicated in PKC1-controlled signalling pathway |
Candida albicans | CaO19.460 | Serine/threonine protein kinase of MAP kinase family |
Caenorhabditis elegans | CELE_F43C1.2 | Protein MPK-1, isoform A |
Cryptosporidium hominis | Chro.30343 | MAPK |
Cryptosporidium parvum | cgd3_3030 | MAPK, putative |
Dictyostelium discoideum | DDB_G0286353 | ERK subfamily protein kinase |
Drosophila melanogaster | Dmel_CG12559 | rolled |
Echinococcus granulosus | EgrG_000803700 | mitogen activated protein kinase 3 |
Echinococcus granulosus | EgrG_000891000 | mitogen activated protein kinase |
Echinococcus multilocularis | EmuJ_000891000 | mitogen activated protein kinase |
Echinococcus multilocularis | EmuJ_000803700 | mitogen activated protein kinase 3 |
Giardia lamblia | GL50803_17563 | Kinase, CMGC MAPK |
Homo sapiens | ENSG00000102882 | mitogen-activated protein kinase 3 |
Homo sapiens | ENSG00000166484 | mitogen-activated protein kinase 7 |
Homo sapiens | ENSG00000100030 | mitogen-activated protein kinase 1 |
Leishmania braziliensis | LbrM.33.1650 | mitogen activated protein kinase, putative,map kinase, putative |
Leishmania braziliensis | LbrM.19.1710 | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440,map kinase |
Leishmania donovani | LdBPK_331470.1 | mitogen activated protein kinase, putative |
Leishmania donovani | LdBPK_191480.1 | mitogen-activated protein kinase 4 |
Leishmania infantum | LinJ.19.1480 | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 |
Leishmania infantum | LinJ.33.1470 | mitogen activated protein kinase, putative,map kinase, putative |
Leishmania major | LmjF.19.1440 | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 |
Leishmania major | LmjF.33.1380 | mitogen activated protein kinase, putative,map kinase, putative |
Leishmania mexicana | LmxM.19.1440 | mitogen-activated protein kinase |
Leishmania mexicana | LmxM.32.1380 | mitogen activated protein kinase, putative,map kinase, putative |
Loa Loa (eye worm) | LOAG_08585 | CMGC/MAPK/ERK1 protein kinase |
Mus musculus | ENSMUSG00000063358 | mitogen-activated protein kinase 1 |
Mus musculus | ENSMUSG00000063065 | mitogen-activated protein kinase 3 |
Mus musculus | ENSMUSG00000001034 | mitogen-activated protein kinase 7 |
Oryza sativa | 4340170 | Os06g0154500 |
Oryza sativa | 4344698 | Os08g0157000 |
Oryza sativa | 4349225 | Os10g0533600 |
Oryza sativa | 4332475 | Os03g0285800 |
Oryza sativa | 4341956 | Os06g0699400 |
Oryza sativa | 4328297 | Os02g0148100 |
Saccharomyces cerevisiae | YGR040W | mitogen-activated serine/threonine-protein kinase KSS1 |
Saccharomyces cerevisiae | YBL016W | mitogen-activated serine/threonine-protein kinase FUS3 |
Saccharomyces cerevisiae | YHR030C | mitogen-activated serine/threonine-protein kinase SLT2 |
Schistosoma japonicum | Sjp_0132780 | Mitogen-activated protein kinase 3, putative |
Schistosoma japonicum | Sjp_0044730 | ko:K04371 extracellular signal-regulated kinase 1/2, putative |
Schistosoma japonicum | Sjp_0035520 | Mitogen-activated protein kinase 3, putative |
Schistosoma mansoni | Smp_142050 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.000508.08 | Mitogen-activated protein kinase ERK-A |
Schmidtea mediterranea | mk4.002179.01 | |
Schmidtea mediterranea | mk4.005156.02 | Mitogen-activated protein kinase ERK-A |
Schmidtea mediterranea | mk4.017998.00 | Mitogen-activated protein kinase mpk-1 |
Schmidtea mediterranea | mk4.016766.00 | Mitogen-activated protein kinase ERK-A |
Schmidtea mediterranea | mk4.001937.03 | Mitogen-activated protein kinase ERK-A |
Schmidtea mediterranea | mk4.009672.00 | Mitogen-activated protein kinase ERK-A |
Schmidtea mediterranea | mk4.000030.09 | |
Schmidtea mediterranea | mk4.015572.01 | |
Trypanosoma brucei gambiense | Tbg972.10.19640 | mitogen-activated protein kinase, putative |
Trypanosoma brucei gambiense | Tbg972.10.14510 | protein kinase, putative,tyrosine protein kinase, putative |
Trypanosoma brucei | Tb927.10.16030 | mitogen activated protein kinase 4, putative |
Trypanosoma brucei | Tb11.v5.1057 | protein kinase, putative |
Trypanosoma congolense | TcIL3000_10_10240 | tyrosine protein kinase, putative |
Trypanosoma cruzi | TcCLB.511299.70 | mitogen activated protein kinase 2, putative |
Trypanosoma cruzi | TcCLB.511837.70 | mitogen-activated protein kinase 11, putative |
Trypanosoma cruzi | TcCLB.506483.69 | mitogen activated protein kinase 4, putative |
Trypanosoma cruzi | TcCLB.510123.20 | mitogen-activated protein kinase 11, putative |
Toxoplasma gondii | TGME49_312570 | CMGC kinase, MAPK family (ERK) MAPK-1 |
Trichomonas vaginalis | TVAG_008800 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_307130 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_258130 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_338030 | CMGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.12040 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.12040 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.12040 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.12040 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.16030 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.16030 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.16030 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.16030 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F43C1.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F43C1.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F43C1.2 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_F43C1.2 | Caenorhabditis elegans | sterile | wormbase |
TGME49_312570 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 1 | Compounds | References |
Mus musculus | mitogen-activated protein kinase 3 | Compounds | References |
Mus musculus | mitogen-activated protein kinase 1 | Compounds | References |
Homo sapiens | mitogen-activated protein kinase 3 | Compounds | References |
Homo sapiens | mitogen-activated protein kinase 7 | Compounds | References |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 33.7% | 312 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 45.9% | 357 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 35.8% | 173 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 33.9% | 313 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 39.5% | 365 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 36.3% | 311 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 36.4% | 316 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 29.0% | 352 aa | Compounds | References |
Zea mays | Casein kinase II alpha | 332 aa | 29.7% | 327 aa | Compounds | References |